Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

I cannot think of a better choice than Bionic P&O as our first distributor for Ekso Indego Personal within the important orthotics and prosthetics industry.” “True innovation that supports patients in ...

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2025 Earnings Call Transcript May 5, 2025 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.11 ...

Through the agreement, Sub-Q Bionics has licensed clinical know-how from Mayo Clinic related to reconstructive and lymphatic surgery. As part of this collaboration, Vahe Fahradyan ...

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release ...